Close

Parkinson’s

What is Parkinson’s Disease?

Parkinson’s disease is a chronic, progressive movement disorder associated with the abnormal function of the central nervous system. The disease becomes expressed with the loss of dopamine-producing brain cells. Dopamine is one of the neurotransmitters which is found to be absent in  patients with Parkinson’s disease. The dopamine is degenerated due to the deposition of proteins (Lewy Bodies) which are observed in the transverse sections of the Parkinson’s brain, which interrupt the transmission of signals leading to progressive degeneration of motor neurons. Patients with the disease experience a substantial detrimental effect to motor coordination, memory, speech, and vision.

Treatment of Parkinson’s at Cellebration Life Sciences, Inc.

By mastering the technology for isolating a maximum number of autologous (your own) or allogeneic (others) stem cells, treatment is implemented in the targeted area where they can colonize in the damaged area, adapt the properties of resident stem cells and initiate lost function that has occurred as an outcome of the disease. Current data suggest evidence of differentiation of stem cells into dopamine producing neurons.

These cells are administered through one of two methods after a considerable analysis of the patient’s unique history and medical professional’s advice.

  • Intrathecal Administration: – In this delivery mode, cells are infused in the cerebrospinal fluid through the subarachnoid spaces of the spinal canal.
  • Intravenous Administration: -In this delivery mode, cells are infused into the peripheral veins to expand blood volumes in the system, to ensure the maximum number of cells are reaching the targeted area.

Infused back into the body, these cells can be repopulated at the damaged parts of the brain. Through paracrine effects, they can differentiate into neurons or other damaged cells to improve functions of the brain. With this approach, it is now possible to obtain notable improvements for patients with Parkinson’s disease to reduce symptoms and improve functional abilities.